Supplementary Methods S1 from The Epstein–Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk PredictionBenjamin E. Warner, Kathy H.Y. Shair|Unknown|2024Cited by 0